SEC Form 4 · accession 0001171843-15-000367
Sucampo Pharmaceuticals, Inc. · SCMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Spiegel
Director
Period of report
Jan 23, 2015
Accepted (ET)
Jan 26, 2015 · 6:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $14.04 | Jan 16, 2015 | A | 30,000 | A | — | Jan 16, 2025 | Class A Common Stock | 30,000 | 30,000 | D |
Explanation of responses
- F1The option vests in 12 equal quarterly installments at the end of each successive three-month period following the grant date through the third anniversary of the grant date.